ArticleLeukemia2024

First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma.

Vincent Cabaud Gibouin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.